Skip to content
PICO Portalanswers from OpenAlex

Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer

PaperCitations, authors & open-access status

Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer have?

PICO Portalcitation count

Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer has 118 citations in the OpenAlex counts PICO Portal stores.

When was Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer published?

PICO Portalyear

Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer has 2010 year in the PICO Portal index.

What is the open-access status of Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?

PICO Portaloa status

Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer has gold oa status in the PICO Portal index.

What is the DOI of Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?

PICO Portaldoi

The DOI for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is on the source record.

What is the PMID of Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?

PICO Portalpmid

The PMID for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is on the source record.

What is the OpenAlex record for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer?

PICO Portalopenalex

The OpenAlex for Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial